![Laurence J. Freedman, Litigation Attorney, Mintz, Enforcement Defense Law](https://www.natlawreview.com/sites/default/files/styles/author_profile/public/images/LaurenceFreedman.jpg?itok=nnhvLX6v)
Larry has a deep understanding of what drives government enforcement actions, and how to defend against them, in the health care and life sciences industries. As a trial lawyer and then official in the Civil Fraud Section of the U.S. Department of Justice, he litigated and supervised hundreds of False Claims Act and qui tam cases nationally. In his litigation practice, Larry has successfully represented hospitals and health care systems, laboratories, pharmaceutical and device manufacturers, and health care executives against fraud and abuse allegations and investigations brought by federal and state agencies. He is consistently recognized among the nation’s leading health care defense attorneys.
Larry’s health care and life sciences litigation practice focuses on defending clients against allegations and investigations of fraud and abuse involving governmental programs. He is highly experienced in representing clients against actions brought by federal and state agencies including the US Department of Justice (DOJ), the Department of Health and Human Services Office of the Inspector General (HHS OIG), the United States Attorneys’ Offices, and state OIGs and Medicaid Fraud Control Units (MFCUs).
Larry’s practice is based on his 24-years of experience handling complex civil litigation, often in the context of parallel proceedings, and achieving global resolutions. In addition to enforcement defense, Larry counsels clients through internal investigations, corporate compliance, investor due diligence reviews, and health care bankruptcies involving governmental liabilities. His clients include hospitals and health systems, dialysis providers, clinical laboratories, medical equipment companies, pharmaceutical and device manufacturers, and health care executives.
Prior to private practice, Larry served as an Assistant Director with the Civil Fraud Section of the DOJ and focused solely on the False Claims Act and its qui tam provisions. At DOJ he supervised hundreds of qui tam cases filed in US district courts throughout the country, was part of the leadership team for the pharmaceutical enforcement initiative, and managed high-profile actions often involving multiple US Attorneys’ Offices and federal agencies.
Prior to his position as Assistant Director, Larry served with the Civil Fraud Section as a trial attorney focused on health care fraud and defense procurement. He co-led the notable investigation and prosecution of national independent clinical laboratories known as “Operation LABSCAM.” For his achievements, Larry was highly-recognized by the Attorney General with the Department’s highest and second highest awards, as well as multiple awards from the HHS OIG and the MFCUs.
Following law school, Larry served as a law clerk for the Honorable Richard Cardamone of the U.S. Court of Appeals for the Second Circuit.
More Legal and Business Bylines From Laurence J. Freedman
- Fifth Circuit Limits FCA Liability Due to Lack of “Materiality” in Highway Guardrails Case - (Posted On Thursday, November 30, 2017)
- Health Care Qui Tam Update: August 2017 - (Posted On Wednesday, September 27, 2017)
- Implied False Certification Theory Fails in FCA Case Against Billing Agent - (Posted On Wednesday, August 23, 2017)
- Hospital and its Clinic Agree to $34 Million Settlement to False Claims Act Allegation that Compensation to Oncologists Violated the Stark Law - (Posted On Wednesday, May 24, 2017)
- Fourth Circuit Permits DOJ to Reject FCA Settlement, But Punts Decision on Statistical Sampling - (Posted On Wednesday, February 22, 2017)
- Tenth Circuit Court Agrees Difference Of Opinion On Medical Necessity Is Insufficient to Show Falsity Under False Claims Act - (Posted On Tuesday, February 14, 2017)
- Massachusetts Jury Acquits in One of First Few Prosecutions of Health Care Executives Following DOJ’s Yates Memo - (Posted On Wednesday, July 27, 2016)
- Senate Committee Releases Report on Potential Stark Law Changes, Hearing Scheduled - (Posted On Thursday, July 07, 2016)
- DOJ Announces Dramatic Increase in False Claims Act Penalties - (Posted On Friday, July 01, 2016)
- Judge Sides with AseraCare, Grants Summary Judgment in $200 Million FCA Case - (Posted On Friday, April 01, 2016)